Email this article Sigma-1 receptor agonist amitriptyline inhibits store-dependent Ca2+ entry in macrophages
- Authors: Krutetskaya Z.I.1, Milenina L.S.1, Antonov V.G.1, Nozdrachev A.D.1,2
-
Affiliations:
- Saint-Petersburg State University
- Pavlov Institute of Physiology of the Russian Academy of Sciences
- Issue: Vol 488, No 2 (2019)
- Pages: 221-224
- Section: Biochemistry, biophysics, molecular biology
- URL: https://journals.eco-vector.com/0869-5652/article/view/16113
- DOI: https://doi.org/10.31857/S0869-56524882221-224
- ID: 16113
Cite item
Full Text
Abstract
Using Fura-2AM microfluorimetry we have shown for the first time that sigma-1 receptor agonist - tricyclic antidepressant amitriptyline - significantly inhibits store-dependent Ca2+ entry, induced by endoplasmic Ca2+-ATPase inhibitors thapsigargin and cyclopiazonic acid, in rat peritoneal macrophages. The results suggest possible involvement of sigma-1 receptors in the regulation of store-dependent Ca2+ entry in macrophages.
About the authors
Z. I. Krutetskaya
Saint-Petersburg State University
Author for correspondence.
Email: z.krutetskaya@spbu.ru
Russian Federation, 7/9, Universitetskaya embankment, Saint-Petersburg, 199034
L. S. Milenina
Saint-Petersburg State University
Email: z.krutetskaya@spbu.ru
Russian Federation, 7/9, Universitetskaya embankment, Saint-Petersburg, 199034
V. G. Antonov
Saint-Petersburg State University
Email: z.krutetskaya@spbu.ru
Russian Federation, 7/9, Universitetskaya embankment, Saint-Petersburg, 199034
A. D. Nozdrachev
Saint-Petersburg State University; Pavlov Institute of Physiology of the Russian Academy of Sciences
Email: a.d.nozdrachev@mail.ru
Academician of the Russian Academy of Sciences
Russian Federation, 7/9, Universitetskaya embankment, Saint-Petersburg, 199034; 6, Makarova street, St.Petersburg, 199034References
- Putney J.W. // Adv. Exp. Med. Biol. 2017. V. 981. P. 205-214.
- Prakriya M., Lewis R.S. // Physiol. Rev. 2015. V. 95. P. 1383-1436.
- Rousseaux C.G., Greene S.F. // J. Recept. Signal Transduct. 2016. V. 36. P. 327-388.
- Penke B., Fulop L., Szucs M., et al. // Curr. Neuropharmacol. 2018. V. 16. P. 97-116.
- Cobos E.J., Entrena J.M., Nieto F.R., et al. // Curr. Neuropharmacol. 2008. V. 6. P. 344-366.
- Villard V., Meunier J., Chevallier N., et al. // J. Pharmacol. Sci. 2011. V. 115. P. 279-292.
- Gillman P.K. // British J. Pharmacol. 2007. V. 151. P. 737-748.
- Миленина Л.С., Крутецкая З.И., Наумова А.А., Бутов С.Н., Крутецкая Н.И., Антонов В.Г. // Цитология. 2015. Т. 57. № 7. С. 518-525.
- Grynkiewicz G., Poenie M., Tsien R.Y. // J. Biol. Chem. 1985. V. 260. P. 3440-3450.
- Xie Q., Zhang Y., Zhai C., et al. // J. Biol. Chem. 2002. V. 277. P. 16559-16566.
- Harper J.L., Daly J.W. // Drug Dev. Res. 1999. V. 47. P. 107-117.
- Brailou G.C., Deliu E., Console-Bram L.M., et al. // Biochem. J. 2016. V. 473. P. 1-5.
- Srivats S., Balasuriya D., Pasche M., et al. // J. Cell Biol. 2016. V. 213. P. 65-79.
- Hamplova-Peichlova J., Krusek J., Paclt I., et al. // Physiol. Res. 2002. V. 51. P. 317-321.
- Zahradnik I., Minarovic I., Zahradnikova Z. // J. Pharmacol. Exper. Therap. 2008. V. 324. P. 977-984.
Supplementary files
